The association of bullous pemphigoid and malignant disease: a case control study

The British Journal of Dermatology
V A Venning, F Wojnarowska

Abstract

In a case control study, the incidence of malignant disease in 84 patients with bullous pemphigoid (BP) was compared with 168 controls. The rate of malignant disease (past, concurrent or during follow-up) in BP patients was 17.9% compared to 5.3% in the controls. A number of the malignancies occurring in the BP group may be of doubtful significance, being either temporally very remote or partially attributable to treatment. The rate of concurrent BP and malignancy (within 8 weeks) was 6.0% suggesting that there is probably a slight excess of malignancy in BP, but insufficient to warrant extensive investigation in pursuit of cancer. Comparison of the BP patients with and without cancer identified no clinical or immunopathological subgroups in whom investigations would be indicated. Three patients with both BP and malignancy were HLA-DR 13 positive, which may point to an immunogenetic predisposition to both diseases.

References

Jun 1, 1978·Archives of Dermatology·T P ChorzelskiL Wronkowski
Mar 1, 1986·Tissue Antigens·G F HendriksJ J van Rood
Apr 1, 1988·British Journal of Urology·H Van PoppelL Baert
Sep 1, 1987·The British Journal of Dermatology·R A Graham-Brown
Apr 1, 1973·The British Journal of Dermatology·N K SaikiaA McQueen
Jun 1, 1970·Archives of Dermatology·M J Tye
Dec 1, 1968·British Journal of Cancer·R L Parsons, J A Savin
Feb 24, 1983·The New England Journal of Medicine·O BinetR Villet
Jan 1, 1982·International Journal of Dermatology·M H AmerP G Butler
Apr 25, 1964·British Medical Journal·R V BOYD
Dec 5, 1964·Nature·P I TERASAKI, J D MCCLELLAND

❮ Previous
Next ❯

Citations

Oct 1, 1993·Irish Journal of Medical Science·S EustaceD O'Connell
Jan 19, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Joaquín J Cabrera-RodríguezYésica Ríos Kavadoy
Mar 19, 2015·International Journal of Dermatology·Mahnaz BanihashemiHamed S Razavi
Oct 6, 2015·The Journal of Dermatology·Riccardo BalestriFederico Bardazzi
Jan 1, 1995·Clinical and Experimental Dermatology·N SheerinD A Burns
Jul 2, 2009·The British Journal of Dermatology·G MarazzaUNKNOWN Autoimmune bullous disease Swiss study group
Apr 12, 2006·American Journal of Clinical Dermatology·C Elise KleynHazel K Bell
May 29, 2010·The Journal of Dermatology·Ayano UmekojiMasamitsu Ishii
Apr 29, 2014·Anais Brasileiros De Dermatologia·Vera Barreto TeixeiraAmérico Figueiredo
Oct 6, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·D D OhD F Murrell
Sep 1, 1991·Clinical and Experimental Dermatology·A AnsteyG N Rutty
Feb 12, 1998·The British Journal of Dermatology·R Parslew, J L Verbov
Apr 16, 2002·Clinical and Experimental Dermatology·P D YesudianR M Azurdia
Dec 22, 1999·Clinical and Experimental Dermatology·E GilmourC E Griffiths
Feb 13, 2001·Clinical and Experimental Dermatology·P D YesudianR Parslew
Mar 2, 2017·American Journal of Clinical Dermatology·Philippe Bernard, Frank Antonicelli
Jan 10, 2018·The Australasian Journal of Dermatology·Richard J LucarielloMartin Reichel
Oct 28, 2019·The Journal of Dermatology·Hideyuki UjiieUNKNOWN Committee for Guidelines for the Management of Pemphigoid Diseases (Including Epidermolysis Bullosa Acquisita)
Aug 14, 2002·The British Journal of Dermatology·F WojnarowskaUNKNOWN British Association of Dermatologists
Aug 1, 2014·Wiener medizinische Wochenschrift·Andrea Kneisel, Michael Hertl
Aug 6, 2017·Clinical Reviews in Allergy & Immunology·Kyle T AmberLuca Borradori
Dec 29, 2020·The Journal of Dermatology·Khalaf KridinArnon D Cohen
Apr 11, 2020·The Journal of Allergy and Clinical Immunology·Shohei EgamiMasayuki Amagai
May 25, 2021·JAAD Case Reports·Erica Ann Grilletta, Darrel Lynn Ellis
Dec 28, 2007·Advances in Dermatology·Giovanni Di ZenzoLuca Borradori

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annales de dermatologie et de vénéréologie
N Delpuget-BertinJ M Bonnetblanc
Annales de dermatologie et de vénéréologie
M MokniA Ben Osman Dhahri
La Tunisie médicale
Hatem Ben JaziaInçaf Mokhtar
Acta Dermato-venereologica
A Al-NajjarS S Bleehen
© 2021 Meta ULC. All rights reserved